Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Random, Open-label, Parallel-group Study to Assess the Pharmacokinetics of JT001 in Subjects With Mild and Moderate Renal Impairment Compared to Subjects With Normal Renal Function

NCT05895812 is registered in ClinicalTrials.gov with Shanghai Vinnerna Biosciences Co., Ltd. as lead sponsor.

NCT NCT05895812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05895812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Random, Open-label, Parallel-group Study to Assess the Pharmacokinetics of JT001 in Subjects With Mild and Moderate Renal Impairment Compared to Subjects With Normal Renal Function
Lead sponsor
Shanghai Vinnerna Biosciences Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
May 8, 2023
Completion date
August 28, 2023
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects, subjects with renal impairment